Zambon S.p.A., an international pharmaceutical company strongly committed to the central nervous system (CNS) therapeutic area, headquartered in Bresso (Milan, Italy), and its partner Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous

Ginkgo Bioworks and Amyris, Inc. announced a new partnership, which will enable the companies to jointly develop products more efficiently and cost effectively, accelerating time to market. This breakthrough biotech partnership creates clear leadership with a combined offering that has successfully introduced more bio-based products than

Enerkem Inc., a Canadian waste-to-biofuels and chemicals producer, yesterday announced it has obtained certification from the International Sustainability and Carbon Certification (ISCC) system for the biomethanol production of its Enerkem Alberta Biofuels full-scale facility in Edmonton, Canada. This biorefinery therefore becomes the first ISCC certified